The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II study of lymphodepletion plus adoptive cell transfer (ACT) with T cells transduced with CXCR2 and NGFR followed by high dose interleukin-2 (IL-2) in patients with metastatic melanoma (MM).
 
Rodabe Navroze Amaria
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst)
 
Cara L. Haymaker
Research Funding - Idera; Nektar
 
Chantale Bernatchez
Employment - Lexicon (I)
Stock and Other Ownership Interests - Lexicon (I)
Consulting or Advisory Role - Lion Biotechnologies
Research Funding - Idera; Nektar
Patents, Royalties, Other Intellectual Property - Patent pending on BTLA as a marker for better CD8 T cells for adoptive immunotherapy
 
Marie-Andree Forget
No Relationships to Disclose
 
Vruti Patel
No Relationships to Disclose
 
Wen-Jen Hwu
No Relationships to Disclose
 
Michael A. Davies
Consulting or Advisory Role - Genentech/Roche; GlaxoSmithKline; Novartis; Sanofi
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Myriad Genetics (Inst); Oncothyreon (Inst); Sanofi (Inst)
 
Sapna Pradyuman Patel
Stock and Other Ownership Interests - Provectus
Honoraria - Dava Oncology; PCME, Rockpointe; PlatformQ Health
Consulting or Advisory Role - Amgen; Genentech/Roche
Speakers' Bureau - Bristol-Myers Squibb (Mexico); Merck
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Celldex (Inst); Deciphera (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Prometheus (Inst); Reata Pharmaceuticals (Inst)
 
Adi Diab
Consulting or Advisory Role - Celgene; CureVac; Nektar
Research Funding - Celgene; Idera; Nektar; Pfizer
Travel, Accommodations, Expenses - Nektar
 
Isabella Claudia Glitza
Travel, Accommodations, Expenses - Lilly
 
Hussein Abdul-Hassan Tawbi
No Relationships to Disclose
 
Scott Eric Woodman
No Relationships to Disclose
 
Jennifer Ann Wargo
Research Funding - Novartis (Inst)
 
Merrick I. Ross
No Relationships to Disclose
 
Jeffrey Edwin Lee
No Relationships to Disclose
 
Jeffrey E. Gershenwald
Consulting or Advisory Role - Castle Biosciences; Merck; Navidea
Patents, Royalties, Other Intellectual Property - mercator therapeutics
 
Janice N. Cormier
No Relationships to Disclose
 
Richard Eldon Royal
No Relationships to Disclose
 
Anthony Lucci
No Relationships to Disclose
 
Patrick Hwu
Consulting or Advisory Role - Lion Biotechnologies
Research Funding - Bristol-Myers Squibb; Genentech